Non-Dioxin-Like Polychlorinated Biphenyls
Polychlorinated biphenyls (PCBs) are a class of chlorinated aromatic hydrocarbon chemicals that once were used as heat-exchanger, transformer, and hydraulic fluids, and as additives to paints, oils, joint caulking, and floor tiles. Peak production occurred in the early 1970s, and production was banned in the United States after 1979. More than 1.5 billion pounds of PCBs were manufactured in the United States prior to 1977. The continued concern about these chemicals is because of their persistence in the environment and accumulation in wildlife and the animal food chain.
Food is the main source of exposure for the general population. PCBs enter the food chain by a variety of routes, including migration into food from external sources, contamination of animal feeds, and accumulation in the fatty tissues of animals. PCBs are found at higher concentrations in fatty foods (e.g., dairy products and fish). The transfer of PCBs from mother to infant via breast milk is another important source of exposure. The lesser-chlorinated PCBs are more volatile and indoor inhalational exposure from buildings containing caulking made with these PCBs prior to 1979 can increase background serum levels (Johansson et al., 2003; Kohler et al., 2005).Other sources of exposure in the general population include the release of these chemicals from PCB-containing waste sites and from fires involving transformers and capacitors. Additionally, the heat from fires can result in the production of polychlorinated dibenzofurans from PCBs. In certain occupational settings, workers can be exposed to PCBs when repairing or manufacturing transformers, capacitors, and hydraulic systems, and when remediating hazardous-waste sites. Both U.S. FDA and OSHA have developed criteria on the allowable levels of these chemicals in foods and the workplace. The U.S. EPA has also set criteria for allowable levels in water and waste materials. The international Stockholm Convention on Persistent Organic Pollutants of 2001 establishes the most stringent guidelines to date regarding elimination, restriction and unintentional production of PCBs and selected organochlorine chemicals (Porta and Zumeta, 2002).
Exposure to these chemicals nearly always occurs as mixtures rather than from individual PCBs. The different types of PCB chemicals are known as congeners, which are compounds that are distinguished by the number of chlorine atoms and their location on the biphenyl structure. PCB congeners can be divided into the coplanar, the mono-ortho-substituted PCBs, and other non-dioxin-like PCBs. The significance of this designation is that the coplanar and some of the mono-ortho-substituted PCBs have dioxin-like toxicologic effects. Structural nomenclature is available at: https://www.epa.gov/oswer/riskassessment/pdf/1340-erasc-003.pdfpdf iconexternal icon.The non-dioxin-like PCBs and their metabolites do not interact substantially with the aryl hydrocarbon receptor (AhR) and may act through different pathways than the dioxin-like chemicals, so their effects are not represented in the use of toxic equivalency factors (TEFs) (Carpenter, 2006).Commonly measured non-dioxin-like PCBs are listed in the table.
Non-Dioxin-like Polychlorinated Biphenyls Measured in the National Biomonitoring Program
|Non-dioxin-like polychlorinated biphenyls (IUPAC number)||CAS number|
|Polychlorinated biphenyls (general class)||1336-36-3|
|2,4,4′-Trichlorobiphenyl (PCB 28)||7012-37-5|
|2,2′,3,5′-Tetrachlorobiphenyl (PCB 44)||41464-39-5|
|2,2′,4,5′-Tetrachlorobiphenyl (PCB 49)||41464-40-8|
|2,2′,5,5′-Tetrachlorobiphenyl (PCB 52)||35693-99-3|
|2,3′,4,4′-Tetrachlorobiphenyl (PCB 66)||32598-10-0|
|2,4,4′,5-Tetrachlorobiphenyl (PCB 74)||32690-93-0|
|2,2′,3,4,5′-Pentachlorobiphenyl (PCB 87)||38380-02-8|
|2,2′,4,4′,5-Pentachlorobiphenyl (PCB 99)||38380-01-7|
|2,2′,4,5,5′-Pentachlorobiphenyl (PCB 101)||37680-73-2|
|2,3,3′,4′,6-Pentachlorobiphenyl (PCB 110)||38380-03-9|
|2,2′,3,3′,4,4′-Hexachlorobiphenyl (PCB 128)||38380-07-3|
|2,2′,3,4,4′,5′-Hexachlorobiphenyl (PCB 138)||35065-28-2|
|2,3,3′,4,4′,6-Hexachlorobiphenyl (PCB 158)||74472-42-7|
|2,2′,3,4′,5,5′-Hexachlorobiphenyl (PCB 146)||51908-16-8|
|2,2′,3,4′,5′,6-Hexachlorobiphenyl (PCB 149)||38380-04-0|
|2,2′,3,5,5′,6-Hexachlorobiphenyl (PCB 151)||52663-63-5|
|2,2′,4,4′,5,5′-Hexachlorobiphenyl (PCB 153)||35065-27-1|
|2,2′,3,3′,4,4′,5-Heptachlorobiphenyl (PCB 170)||35065-30-6|
|2,2′,3,3′,4,5,5′-Heptachlorobiphenyl (PCB 172)||52663-74-8|
|2,2′,3,3′,4,5′,6′-Heptachlorobiphenyl (PCB 177)||52663-70-4|
|2,2′,3,3′,5,5′,6-Heptachlorobiphenyl (PCB 178)||52663-67-9|
|2,2′,3,4,4′,5,5′-Heptachlorobiphenyl (PCB 180)||35065-29-3|
|2,2′,3,4,4′,5′,6-Heptachlorobiphenyl (PCB 183)||52663-69-1|
|2,2′,3,4′,5,5′,6-Heptachlorobiphenyl (PCB 187)||52663-68-0|
|2,2′,3,3′,4,4′,5,5′-Octachlorobiphenyl (PCB 194)||35694-08-7|
|2,2′,3,3′,4,4′,5,6-Octachlorobiphenyl (PCB 195)||52663-78-2|
|2,2′,3,3′,4,4′,5,6′-Octachlorobiphenyl (PCB 196)||42740-50-1|
|2,2′,3,3′,4,5,5′,6′-Octachlorobiphenyl (PCB 199)||52663-75-9|
|2,2′,3,4,4′,5,5′,6-Octachlorobiphenyl (PCB 203)||52663-76-0|
|2,2′,3,3′,4,4′,5,5′,6-Nonachlorobiphenyl (PCB 206)||40186-72-9|
|2,2’3,3’4,4’5,5’6,6′-Decachlorobiphenyl (PCB 209)||2051-24-3|
Human health effects that have been reported after investigations of occupational and accidental exposures to high levels of PCBs include elevations of serum hepatic enzymes, dermal changes, inconsistent associations with serum lipid levels, and some types of cancer (e.g., liver, biliary) (ATSDR, 2000; Carpenter, 2006; Charles et al., 2001; Negri et al., 2003). Animal studies have demonstrated varied effects of PCBs including neurotoxicity, immune suppression, altered thyroid and reproductive function, and liver cancer (Carpenter, 2006; U.S.EPA, 2008). Effects of PCBs in humans are difficult to study because of co-exposures to the dioxin-like chemicals and other organochlorine chemicals.
Transplacental transfer of PCBs after maternal environmental exposure has been reported to be associated with altered psychomotor development in children and lower birth weight and size in newborns ( Hertz-Picciotto et al., 2005; Jacobson and Jacobson, 1996; Koopman-Essenboom et al., 1996; Longnecker et al., 2003; Lundqvist et al., 2006; Sagiv et al., 2007; Sala et al., 2001), although other studies have either not confirmed these findings or found that such effects do not persist into toddler and school aged children (Gladen and Rogan, 1991; Gray et al., 2005; Hertz-Picciotto et al., 2005; Koopman-Essenboom et al., 1996; Wolff et al., 2007). Many animal studies demonstrate that high dose PCB impairs neurodevelopment or their hydroxylated metabolites may interfere with thyroid hormone-dependent neurodevelopment (Kimura-Kuroda et al., 2007; Nguon et al., 2005; Purkey et al., 2004; Roegge et al., 2006).
The non-dioxin-like PCBs weakly interact with estrogen and thyroid receptors and with transport proteins, and the hydroxylated metabolites of PCBs may be more potent mediators of these actions (Azulmozhiraja et al., 2005; DeCastro et al., 2006; Langer et al., 2005; Purkey et al., 2004; Kitamura etal., 2005; You et al., 2006). Variations in thyroid hormone levels have been associated with PCB exposures in human populations (Langer et al., 2007a; Meeker et al., 2007; Otake et al., 2007; Wang et al., 2005). Though only limited investigation of estrogenic or reproductive effects has occurred in women, inconsistent associations of PCB levels with altered spermatogenesis and reproductive hormone levels have been reported in environmentally exposed men (Giwercman et al., 2006; Rignell-Hydbom et al., 2005; Toft et al., 2006).
PCBs are not considered directly genotoxic. They are classified as probable human carcinogens by IARC and are classified by NTP as reasonably anticipated to be carcinogens. Early studies associated workplace PCB exposures with increased deaths from cancer of the liver, gallbladder, biliary tract, gastrointestinal tract, brain and malignant melanoma (Knerr and Schrenk, 2006).Follow up studies of these earlier investigations have shown no increase in deaths or cancers, with the exception of liver cancer (Kimbrough et al., 2003; Prince et al., 2006; Ross, 2004), though the contributions of dioxin-like chemicals or other organochlorines were unclear. Recent studies have associated PCB exposures with other cancers (De Roos et al., 2005; Engel et al., 2007; Prince et al., 2006). Information about external exposure (i.e., environmental levels) and health effects is available from ATSDR at https://www.atsdr.cdc.gov/toxprofiles/index.aspand from the U.S. EPA at https://www.epa.gov/irisexternal icon.
Measurement of serum PCBs generally reflect cumulative past exposure. Levels of non-dioxin-like PCBs in NHANES 2003-2004 are observed to be roughly similar to the previous two NHANES survey periods CDC, 2013). Many PCBs can remain in the body for years after exposure, though some of the PCBs with fewer chlorine atoms have short residence times. The levels of individual PCB congeners in the body may vary by exposure source and by differences in pharmacokinetics, i.e., those with longer half-lives accumulate to higher levels. Adult age-related accumulations in the non-dioxin-like PCBs have been observed in many studies (Apostoli et al., 2005; Park et al., 2007; Patterson et al., 1994). Breastfeeding is a major source of PCBs, with serum levels increasing after birth in breastfed infants and then decreasing in early adolescence due to dilution as body mass increases (Barr et al., 2006). Fish consumption from the Great Lakes region contributed a twofold to tenfold increase in the mean concentrations of non-dioxin-like PCBs over referent populations (Patterson et al., 1994; Turyk et al., 2006).Arctic native Alaskans who consumed locally-caught fish, meat, and eggs had mean serum levels of total PCB that were nearly three times higher than the adult NHANES 1999-2000 subsample (Carpenter et al., 2005; CDC, 2013; Needham et al., 2005). Much higher levels due to contaminated fish intake have also been noted in eastern Europe (Langer et al., 2007b).
The concentrations of the di-ortho-substituted PCBs were usually higher than the mono-ortho-substituted PCBs, which in turn were higher than the coplanar PCBs (CDC, 2013; Glynn et al., 2000; Longnecker et al., 2000; Patterson et al., 1994). The most frequently detected di-ortho-chlorine-substituted PCBs in population studies are 138, 153, and 180 (CDC, 2013; Heudorf et al., 2002; Patterson et al., 1994, 2009; Turyk et al., 2006). These three congeners contributed a substantial portion of the total PCB concentration observed in pooled specimens representative of a New Zealand population (Bates et al., 2004); in a small population of Swedish men (Glynn et al., 2000), and in blood bank specimens from Canada (Longnecker et al., 2000). In the U.S representative subsample from NHANES 1999-2000, non-dioxin-like PCBs 138, 153, and 180 accounted for 65% of the measured total sum of PCBs (Needham et al., 2005) and for 78% of the total in a referent population of 311 Italian residents in 2001-2003 (Apostoli et al., 2005). Non-dioxin-like PCBs with five, six, and seven chlorines attached comprised about 80% of the total PCBs in human serum, or alternatively, PCBs 138, 153, 180, 187 and 118 composed 57% of the total PCB concentration in a small sample of South Korean residents and incineration workers (Park et al., 2007).In the sera of Yucheng victims analyzed 15 years after the rice oil contamination event, 73% of the total PCB concentration was contributed by PCBs 99, 138, 153, 156, 170, 179, and 180 (Hsu et al., 2005).
Median serum lipid-adjusted levels of PCB 153 declined by 38% from 1991 to 2001 in a small sample of Swedish men (Hagmar et al., 2006). In four biannual surveys covering the years 1996-2003, about 400 German fourth grade children were sampled each period and demonstrated a decrease of more than one-half in mean whole blood levels of PCBs 138, 153, and 180 (Link et al., 2005). Lipid adjusted levels of the non-dioxin-like PCBs seen in the U.S representative subsamples from NHANES 2001-2002 were generally lower than levels in selected populations during the 1980s to 1990s (CDC, 2013; Glynn et al., 2000; Longnecker et al., 2000; Patterson et al., 1994).
In a convenience sample of 624 urban Germans aged 0-65 years conducted during 1998 (Heudorf et al., 2002), 95th percentile levels for PCBs 138, 153, and 180 were similar or up to two times higher than 95th percentile levels in the NHANES 1999-2000 subsample (CDC, 2013).In contrast, levels in pooled serum samples from a representative population of New Zealand residents in 1996-1997 were slightly lower than NHANES 1999-2000 (Bates et al., 2004). In two separate Italian studies of a regional reference population and a convenience sample in 2001-2003, median serum levels of PCBs 138, 153, and 180, as well as the sum of measurable PCBs, were about five times higher than NHANES 1999-2000 (Apostoli et al., 2005; CDC, 2013; Needham et al., 2005; Turci et al., 2006).The mean levels of PCBs 153 and 180 in 753 adult native Americans were approximately similar to the 95th percentile for the overall adult NHANES 2001-2002 population (CDC, 2013; DeCaprio et al., 2005). In some other countries, comparable population levels were ten or more times higher than those reported for NHANES subsamples from 1999-2000 and 2001-2002 (CDC, 2013; Jursa et al.,2006; Petrik et al., 2006). In the sera of Yucheng victims analyzed 15 years after the contamination event, mean serum lipid adjusted levels of PCBs 99, 153, 170, and 180 were up to eight times higher than the 95th percentiles of NHANES 1999-2000 (Hsu et al., 2005).
Finding a measurable amount of one or more PCBs in serum does not mean that the levels of the PCBs cause an adverse health effect. Biomonitoring studies of serum PCBs can provide physicians and public health officials with reference values so that they can determine whether or not people have been exposed to higher levels of PCBs than levels found in the general population. Biomonitoring data can also help scientists plan and conduct research on exposure and health effects.
Agency for Toxic Substances and Disease Registry (ATSDR). Toxicological profile for polychlorinated biphenyls. 2000 [online]. Available from URL: https://www.atsdr.cdc.gov/toxprofiles/tp.asp?id=142&tid=26. 03/15/13.
Apostoli P, Magoni M, Bergonzi R, Carasi S, Indelicato A, Scarcella C, et al. Assessment of reference values for polychlorinated biphenyl concentration in human blood. Chemosphere 2005;61(3):413-21.
Arulmozhiraja S, Shiraishi F, Okumura T, Iida M, Takigami H, Edmonds JS, et al. Structural requirements for the interaction of 91 hydroxylated polychlorinated biphenyls with estrogen and thyroid hormone receptors. Toxicol Sci 2005;84(1):49-62.
Barr DB, Weihe P, Davis MD, Needham LL, Grandjean P. Serum polychlorinated biphenyl and organochlorine insecticide concentrations in a Faroese birth cohort. Chemosphere 2006;62(7):1167-82.
Bates MN, Buckland SJ, Garrett N, Ellis H, Needham LL, Patterson DG Jr, et al. Persistent organochlorines in the serum of the non-occupationally exposed New Zealand population. Chemosphere 2004;54:1431-43.
Carpenter DO, DeCaprio AP, O’Hehir D, Akhtar F, Johnson G, Scrudato RJ, et al. Polychlorinated biphenyls in serum of the Siberian Yupik people from St. Lawrence Island, Alaska. Int J Circumpolar Health 2005;64(4):322-35.
Carpenter DO. Polychlorinated biphenyls (PCBs): routes of exposure and effects on human health. Rev Environ Health 2006;21(1):1-23.
Centers for Disease Control and Prevention (CDC). Fourth National Report on Human Exposure to Environmental Chemicals. Updated Tables. September 2013. [online] Available at URL: https://www.cdc.gov/exposurereport/. 9/15/13
Charles MJ, Schell MJ, Willman E, Gross HB, Lin Y, Sonnenberg S, et al. Organochlorines and 8-hydroxy-2-deoxyguanosine in cancerous and noncancerous breast tissue: do the data support the hypothesis that oxidative DNA damage caused by organochlorines affects breast cancer? Arch Environ Contam Toxicol 2001;41:386-95.
De Roos AJ, Hartge P, Lubin JH, Colt JS, Davis S, Cerhan JR, et al. Persistent organochlorine chemicals in plasma and risk of non-Hodgkin’s lymphoma. Cancer Res 2005;65(23):11214-26.
DeCaprio AP, Johnson GW, Tarbell AM, Carpenter DO, Chiarenzelli JR, Morse GS, et al. Polychlorinated biphenyl (PCB) exposure assessment by multivariate statistical analysis of serum congener profiles in an adult Native American population. Environ Res 2005;98(3):284-302.
DeCastro BR, Korrick SA, Spengler JD, Soto AM. Estrogenic activity of polychlorinated biphenyls present in human tissue and the environment. Environ Sci Technol 2006;40(8):2819-25.
Engel LS, Laden F, Andersen A, Strickland PT, Blair A, Needham LL, et al. Polychlorinated biphenyl levels in peripheral blood and non-Hodgkin’s lymphoma: a report from three cohorts. Cancer Res 2007;67(11):5545-52.
Giwercman AH, Rignell-Hydbom A, Toft G, Rylander L, Hagmar L, Lindh C, et al. Reproductive hormone levels in men exposed to persistent organohalogen pollutants: a study of Inuit and three European cohorts. Environ Health Perspect 2006;114(9):1348-53.
Gladen BC, Rogan WJ. Effects of perinatal polychlorinated biphenyls and dichlorodiphenyl dichloroethene on later development. J Pediatr 1991;119(1 ( Pt 1)):58-63.
Glynn A, Aune M, Darnerud PO, Cnattingius S, Bjerselius R, Becker W, et al.. Determinants of serum concentrations of organochlorine compounds in Swedish pregnant women: a cross-sectional study. Environ Health. 2007;6:2.
Glynn AW, Wolk A, Aune M, Atuma S, Zettermark S, Maehle-Schmid M, et al. Serum concentrations of organochlorines in men: a search for markers of exposure. Sci Total Environ 2000; 263(1-3):197-208.
Gray KA, Klebanoff MA, Brock JW, Zhou H, Darden R, Needham L, Longnecker MP. In utero exposure to background levels of polychlorinated biphenyls and cognitive functioning among school-age children. Am J Epidemiol 2005;162(1):17-26.
Hagmar L, Wallin E, Vessby B, Jonsson BA, Bergman A, Rylander L. Intra-individual variations and time trends 1991-2001 in human serum levels of PCB, DDE and hexachlorobenzene. Chemosphere 2006;64(9):1507-13.
Hertz-Picciotto I, Charles MJ, James RA, Keller JA, Willman E, Teplin S. In utero polychlorinated biphenyl exposures in relation to fetal and early childhood growth. Epidemiology 2005;16(5):648-56.
Heudorf U, Angerer J, Drexler H. Polychlorinated biphenyls in the blood plasma:current exposure of the population in Germany. Rev Environ Health 2002;17(2):123-34.
Hsu JF, Guo YL, Yang SY, Liao PC. Congener profiles of PCBs and PCDD/Fs in Yucheng victims fifteen years after exposure to toxic rice-bran oils and their implications for epidemiologic studies. Chemosphere 2005;61(9):1231-43.
Jacobson JL, Jacobson SW. Intellectual impairment in children exposed to polychlorinated biphenyls in utero. N Engl J Med 1996;335:783-9.
Johansson N, Hanber A, Wingfors H, Tysklind M.PCB in building sealant is influencing PCB levels in blood of residents.Organohalogen Compounds, Volumes 60-65, Dioxin 2003.Boston, MA.
Jursa S, Chovancova J, Petrik J, Loksa J. Dioxin-like and non-dioxin-like PCBs in human serum of Slovak population. Chemosphere. 2006;64(4):686-91.
Kimbrough RD, Doemland ML, Mandel JS. A mortality update of male and female capacitor workers exposed to polychlorinated biphenyls. J Occup Environ Med 2003;45(3):271-82.
Kimura-Kuroda J, Nagata I, Kuroda Y. Disrupting effects of hydroxy-polychlorinated biphenyl (PCB) congeners on neuronal development of cerebellar Purkinje cells: a possible causal factor for developmental brain disorders? Chemosphere 2007;67(9):S412-20.
Kitamura S, Jinno N, Suzuki T, Sugihara K, Ohta S, Kuroki H, et al. Thyroid hormone-like and estrogenic activity of hydroxylated PCBs in cell culture. Toxicology 2005 Mar 30;208(3):377-87.
Kohler M, Tremp J, Zennegg M, Seiler C, Minder-Kohler S, Beck M, et al. Joint sealants: an overlooked diffuse source of polychlorinated biphenyls in buildings. Environ Sci Technol 2005;39(7):1967-73.
Knerr S, Schrenk D. Carcinogenicity of “non-dioxinlike” polychlorinated biphenyls. Crit Rev Toxicol. 2006;36(9):663-94.
Koopman-Esseboom C, Weisglas-Kuperus N, de Ridder MA, Van der Paauw CG, Tuinstra LG, Sauer PJ. Effects of polychlorinated biphenyl/dioxin exposure and feeding type on infants’ mental and psychomotor development. Pediatrics 1996;97(5):700-6.
Langer P, Kocan A, Tajtakova M, Petrik J, Chovancova J, Drobna B, et al. Human thyroid in the population exposed to high environmental pollution by organochlorinated pollutants for several decades. Endocr Regul 2005;39(1):13-20.
Langer P, Tajtakova M, Kocan A, Petrik J, Koska J, Ksinantova L, etal. Thyroid ultrasound volume, structure and function after long-term high exposure of large population to polychlorinated biphenyls, pesticides and dioxin. Chemosphere. 2007a;69(1):118-27.
Langer P, Kocan A, Tajtakova M, Petrik J, Chovancova J, Drobna B, et al. Fish from industrially polluted freshwater as the main source of organochlorinated pollutants and increased frequency of thyroid disorders and dysglycemia. Chemosphere 2007b;67(9):S379-85.
Link B, Gabrio T, Zoellner I, Piechotowski I, Paepke O, Herrmann T, et al. Biomonitoring of persistent organochlorine pesticides, PCDD/PCDFs and dioxin-like PCBs in blood of children from South West Germany (Baden-Wuerttemberg) from 1993 to 2003. Chemosphere 2005;58(9):1185-1201.
Longnecker MP, Ryan JJ, Gladen BC, Schecter AJ. Correlations among human plasma levels of dioxin-like compounds and polychlorinated biphenyls (PCBs) and implications for epidemiologic studies. Arch Environ Health 2000;55(3):195-200.
Longnecker MP, Wolff MS, Gladen BC, Brock JW, Grandjean P, Jacobson JL, et al. Comparison of polychlorinated biphenyl levels across studies of human neurodevelopment. Environ Health Perspect 2003;111(1):65-70.
Lundqvist C, Zuurbier M, Leijs M, Johansson C, Ceccatelli S, Saunders M, et al. The effects of PCBs and dioxins on child health. Acta Paediatr Suppl 2006;95(453):55-64.
Meeker JD, Altshul L, Hauser R. Serum PCBs, p,p(‘)-DDE and HCB predict thyroid hormone levels in men. Environ Res 2007;104(2):296-304.
Negri E, Bosetti C, Fattore E, La Vecchia C. Environmental exposure to polychlorinated biphenyls (PCBs) and breast cancer: a systemic review of the epidemiological evidence. Eur J Cancer Prev 2003;12:509-16.
Needham LL, Barr DB, Caudill SP, Pirkle JL, Turner WE, Osterloh J, et al. Concentrations of environmental chemicals associated with neurodevelopmental effects in U.S. population. Neurotoxicology 2005;26(4):531-45.
Nguon K, Baxter MG, Sajdel-Sulkowska EM. Perinatal exposure to polychlorinated biphenyls differentially affects cerebellar development and motor functions in male and female rat neonates. Cerebellum 2005;4(2):112-22.
Otake T, Yoshinaga J, Enomoto T, Matsuda M, Wakimoto T, Ikegami M, et al. Thyroid hormone status of newborns in relation to in utero exposure to PCBs and hydroxylated PCB metabolites. Environ Res 2007;105(2):240-6.
Park H, Lee SJ, Kang JH, Chang YS. Congener-specific approach to human PCB concentrations by serum analysis. Chemosphere 2007;68(9):1699-1706.
Patterson DG Jr, Todd GD, Turner WE, Maggio V, Alexander LR, Needham LL. Levels of non-ortho-substituted (coplanar), mono- and di-ortho-substituted polychlorinated biphenyls, dibenzo-p-dioxins, and dibenzofurans in human serum and adipose tissue. Environ Health Perspect 1994;102 (Suppl 1):195-204.
Patterson DG Jr, Wong LY, Turner WE, Caudill SP, Dipietro ES, McClure PC, et al.
Levels in the U.S. population of those persistent organic pollutants (2003-2004)
included in the Stockholm Convention or in other long range transboundary air
pollution agreements. Environ Sci Technol 2009;43(4):1211-8.
Petrik J, Drobna B, Pavuk M, Jursa S, Wimmerova S, Chovancova J. Serum PCBs and organochlorine pesticides in Slovakia: age, gender, and residence as determinants of organochlorine concentrations. Chemosphere 2006;65(3):410-8.
Porta M, Zumeta E. Implementing the Stockholm treaty on persistent organic pollutants. Occup Environ Med 2002;59:651-3.
Prince MM, Ruder AM, Hein MJ, Waters MA, Whelan EA, Nilsen N, et al. Mortality and exposure response among 14,458 electrical capacitor manufacturing workers exposed to polychlorinated biphenyls (PCBs). Environ Health Perspect 2006;114(10):1508-14.
Purkey HE, Palaninathan SK, Kent KC, Smith C, Safe SH, Sacchettini JC, et al. Hydroxylated polychlorinated biphenyls selectively bind transthyretin in blood and inhibit amyloidogenesis: rationalizing rodent PCB toxicity. Chem Biol 2004;11(12):1719-28.
Rignell-Hydbom A, Rylander L, Elzanaty S, Giwercman A, Lindh CH, Hagmar L. Exposure to persistent organochlorine pollutants and seminal levels of markers of epididymal and accessory sex gland functions in Swedish men. Hum Reprod 2005;20(7):1910-4.
Roegge CS, Morris JR, Villareal S, Wang VC, Powers BE, Klintsova AY, et al. Purkinje cell and cerebellar effects following developmental exposure to PCBs and/or MeHg. Neurotoxicol Teratol 2006;28(1):74-85.
Ross G. The public health implications of polychlorinated biphenyls (PCBs) in the environment. Ecotoxicol Environ Saf 2004;59(3):275-91.
Sagiv SK, Tolbert PE, Altshul LM, Korrick SA. Organochlorine exposures during pregnancy and infant size at birth. Epidemiology 2007;18(1):120-9.
Sala M, Ribas-Fito N, Cardo E, de Muga ME, Marco E, Mazon C, et al. Levels of hexachlorobenzene and other organochlorine compounds in cord blood: exposure across placenta. Chemosphere 2001;43:895-901.
Toft G, Rignell-Hydbom A, Tyrkiel E, Shvets M, Giwercman A, Lindh CH, et al. Semen quality and exposure to persistent organochlorine pollutants. Epidemiology 2006;17(4):450-548.
Turci R, Finozzi E, Catenacci G, Marinaccio A, Balducci C, Minoia C. Reference values of coplanar and non-coplanar PCBs in serum samples from two Italian population groups. Toxicol Lett 2006;162(2-3):250-5.
Turyk M, Anderson HA, Hanrahan LP, Falk C, Steenport DN, Needham LL, et al. Relationship of serum levels of individual PCB, dioxin, and furan congeners and DDE with Great Lakes sport-caught fish consumption. Environ Res. 2006;100(2):173-83.
United States Environmental Protection Agency (U.S.EPA). Health Effects of PCBs. August 8, 2008 [online].Available at URL:https://www.epa.gov/epawaste/hazard/tsd/pcbs/pubs/effects.htmexternal icon. 3/15/13
Wang SL, Su PH, Jong SB, Guo YL, Chou WL, Papke O. In utero exposure to dioxins and polychlorinated biphenyls and its relations to thyroid function and growth hormone in newborns. Environ Health Perspect 2005;113(11):1645-50.
Wolff MS, Engel S, Berkowitz G, Teitelbaum S, Siskind J, Barr DB, et al. Prenatal pesticide and PCB exposures and birth outcomes. Pediatr Res 2007;61(2):243-50.
You SH, Gauger KJ, Bansal R, Zoeller RT. 4-Hydroxy-PCB106 acts as a direct thyroid hormone receptor agonist in rat GH3 cells. Mol Cell Endocrinol 2006;257-258:26-34.